ArticleBlood advances2022

The TΑp63/BCL2 axis represents a novel mechanism of clinical aggressiveness in chronic lymphocytic leukemia.

Stamatia Laidou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.